Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 3 stocks made the list for top value stocks in the Retailers - Drug industry. Those looking for value stocks to add to their portfolio may want to use this list as a starting point for further investment research.

Latest Retailers - Drug Stock News

Before choosing which top Retailers - Drug stock to buy, be sure to conduct proper due diligence: analyze various financial metrics and look at historical data, public statements and news coverage.

Our 12-month outlook on the drug retail subindustry is neutral. Over the longer term, we have a positive outlook, in part due to an aging overall population, increases in life expectancy, increases in the availability of generic drugs, the continued development of innovative drugs, and increases in the number of individuals who are health insured. However, over the next 12 months, we have a neutral outlook as the competitive environment is evolving and intensifying and shifting consumer habits amid the pandemic could further pressure margins for drug retailers. Drug retailers like Walgreens, CVS, and Rite Aid are playing a part in the Covid-19 testing and vaccination process. Walgreens and CVS played an early role as they partnered with the CDC to offer on-site Covid-19 vaccination services for residents of nursing homes and assisted living facilities. Now, 21 national pharmacies are playing a role to vaccinate the general population. Drug retailers have seen increased foot traffic because of its Covid-19 vaccination services. This has benefited non-pharmacy sales, including beauty products, consumables, and general merchandise items. As for the direct benefits of administering the vaccine, the economics are a bit unclear. Medicare, the health insurance program paid by the government for people mostly 65 or older, will reimburse health providers $40 per shot. However, for other private third-party payors, it is unclear what the reimbursement rate will be, although drug retailers are confident all payors will eventually pay $40 per shot. Drug retailers are now seeing Covid-19 vaccination rates slow, which will be a headwind as this means less reimbursement from Medicare and other third-party payors, as well as less foot traffic within stores. The good news is drug retailers expect to play a role when it comes to providing Covid-19 booster shots. Yet, it is unclear how long these benefits will last. The competitive landscape in retail pharmacy is intensifying and evolving, particularly since Amazon recently expanded its pharmacy offerings with its new Amazon Pharmacy service. We think Amazon Pharmacy has the ability to transform the way millions of people purchase prescription drugs given that there are over 120M Amazon Prime members in the U.S. These households will now be able to purchase certain prescription drugs online, often times at a discount when paying without insurance because of Amazon’s established infrastructre and established supply chains. 

Why Focus on Undervalued Retailers - Drug Stocks?

Value investors seek to buy stocks at a discount to their intrinsic value. Long-term returns show that such strategies are advantageous. Value stocks, as a group, tend to outperform growth stocks over extended periods of time. Typically, value investors perform financial analysis of numerous metrics, don’t follow the herd and are long-term investors.

AAII’s A+ Investor Value Grade is derived from a stock’s Value Score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

What Goes Into AAII’s Value Grade?

Stock evaluation requires access to huge amounts of data as well as the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movement. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors with that task.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for more than just value. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. Some stocks may even have null values for certain metrics like the price-earnings ratio or the price-to-book ratio but not others. An example of this would be a company with losses instead of profits or a negative book value because of heavy borrowing. Negative earnings or book value result in non-meaningful ratios that are left blank or null.

Click the button below to learn more about A+ Investor and subscribe today.

3 Undervalued Retailers - Drug Stocks

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Retailers - Drug industry for Monday, June 19, 2023. Let’s take a closer look at their individual scores to see how they measure up against each other and the Retailers - Drug industry median.

The Value Grade is assigned based on how each stock’s composite valuation compares to all other stocks.

The process for assigning grades starts with each variable for a given stock. The percentile rankings for all valid ratios that a stock has are calculated. So, for instance, a stock could have a price-to-book ranking in the 43rd percentile, a price-earnings ranking in the 67th percentile, a price-to-sales ranking in the 23rd percentile, etc. Then, those rankings are averaged for each stock. (A minimum of two valid variables are required, though all six will be used if available.)

Once the average of the individual variables is calculated, that average is ranked against all stocks. Put another way, each stock’s composite valuation is compared to all other stocks. These ranks are then sorted into quintiles from the cheapest 20% (a grade of A) to the most expensive 20% (a grade of F).

As always, we recommend that you conduct proper due diligence and research before investing in any security. We also suggest that investors utilize numerous grades, not just value, when it comes to deciding whether a company is a good fit for their allocation needs.

China Jo-Jo Drugstores Holdings Inc’s Value Grade

Value Grade:

China Jo-Jo Drugstores Holdings Inc is a China-based retailer and distributor of pharmaceutical and other healthcare products. The Company operates in four business segments. The Retail Drugstores segment sells prescription and over the counter (OTC) medicines, traditional Chinese medicine (TCM), dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment sells OTC drugs, dietary supplements, medical devices and sundry items through its own and third-party platforms. The Drug Wholesale segment includes supplying the Company’s own retail drugstores and selling them to other drug vendors and hospitals. The Herb Farming segment cultivates selected herbs for sales to other drug vendors. The Company is also involved in online sales and clinic services.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

China Jo-Jo Drugstores Holdings Inc has a Value Score of 75, which is considered to be undervalued.

When you look at China Jo-Jo Drugstores Holdings Inc’s price-to-sales ratio at 0.04 compared to the industry median at 0.33, this company has a lower price relative to revenue compared to its peers. This could make China Jo-Jo Drugstores Holdings Inc’s stock more attractive for value investors.

Shareholder yield is the sum of a stock’s dividend yield (paid over previous 12 months minus special dividends) and the percentage of net share buybacks over the previous 12 months. China Jo-Jo Drugstores Holdings Inc’s shareholder yield is lower than its industry median ratio of (1.31%). Value investors may look for an attractive shareholder yield because it can be a powerful tool for identifying if the company has a good management team.

As one of the most common value metrics, the price-to-book ratio evaluates a company’s current market price relative to its book value. China Jo-Jo Drugstores Holdings Inc’s price-to-book ratio is lower than its industry median ratio of 1.67. This could make China Jo-Jo Drugstores Holdings Inc more attractive to investors looking for a new addition to their portfolio.

Yoshitsu Co Ltd (ADR)’s Value Grade

Value Grade:

Yoshitsu Co Ltd is a Japan-based company mainly engaged in the management of pharmacy and sale of health products, beauty products and other groceries. The Company is engaged in the supply of health products include over-the-counter (OTC) drugs, nutritional supplements, and medical supplies and devices. Its beauty products include cosmetics, skin care, fragrance, and body care. Its other products include lingerie, home goods, food, and alcoholic beverages. The Company distributes its products through physical stores, online stores, and franchise stores and wholesale customers.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Yoshitsu Co Ltd (ADR) has a Value Score of 63, which is considered to be undervalued.

Yoshitsu Co Ltd (ADR)’s price-earnings ratio is 31.5 compared to the industry median at 17.4. This means that it has a higher price relative to its earnings compared to its peers. This makes Yoshitsu Co Ltd (ADR) less attractive for value investors.

Yoshitsu Co Ltd (ADR)’s price-to-book ratio is higher than its peers. This could make Yoshitsu Co Ltd (ADR) less attractive for value investors when compared to the industry median at 1.67.

You can read more about Yoshitsu Co Ltd (ADR)’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Walgreens Boots Alliance Inc’s Value Grade

Value Grade:

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company's U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.

Walgreens Boots Alliance Inc has a Value Score of 78, which is considered to be undervalued.

Walgreens Boots Alliance Inc’s price-to-book ratio is higher than its peers. This could make Walgreens Boots Alliance Inc less attractive for value investors when compared to the industry median at 1.67.

You can read more about Walgreens Boots Alliance Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.

Other Retailers - Drug Stock Grades

Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate revisions and quality—on the A+ Stock Grades Screener.

Also, if you want full access to all of AAII’s premium services, you can subscribe to one convenient bundled plan called AAII Platinum where you can try out A+ Investor, AAII Dividend Investing, the Stock Superstars Report, Growth Investing and VMQ Stocks. With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Retailers - Drug stocks as well as other industrys.

Choosing Which of the 3 Best Retailers - Drug Stocks Is Right for You

Choosing which value stocks to invest in will ultimately depend on your individual goals and allocation; however, comparing similar value stocks in the same industry can help you analyze which might be better investments for you in the long run. So, let’s take a look at the Value Grade for all of our stocks.

• China Jo-Jo Drugstores Holdings Inc stock has a Value Grade of B.
• Yoshitsu Co Ltd (ADR) stock has a Value Grade of B.
• Walgreens Boots Alliance Inc stock has a Value Grade of B.

Now that you have a bit more background about each of the 3 undervalued stocks in the Retailers - Drug industry as well as their overall grades, it’s time for you to conduct additional research to see if these could fit your portfolio needs based on your goals and risk tolerance. AAII can help you figure out both and identify which investments align with what works best for you.

We do so through a program of education that teaches you to invest for yourself and become an effective manager of your own wealth—no more relying on others for your financial independence. You can rely on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis that makes you a better investor.

A+ Investor adds to that qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

Additional Resources About Retailers - Drug Stocks

Want to learn more about Retailers - Drug stocks to see if they could be the right investment for you? Check out some additional resources and articles to help you on your financial journey.

• 3 Undervalued Retailers - Drug Stocks for Monday, June 19
• Why Petmed Express Inc’s (PETS) Stock Is Down 6.11%
• 3 Undervalued Retailers - Drug Stocks for Monday, June 12
• 3 Undervalued Retailers - Drug Stocks for Wednesday, June 07

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith and we accept no liability for any errors or omissions. The full disclaimer can be read here.